HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Recombinant cholera toxin B subunit and gene fusion proteins for oral vaccination.

Abstract
The B subunit portion of cholera toxin (CTB) is a safe and effective oral immunizing agent in humans, affording protection against both cholera and diarrhoea caused by enterotoxigenic Escherichia coli producing heat-labile toxin (LT) (Clemens et al., 1986; 1988). CTB may also be used as a carrier of various "foreign" antigens suitable for oral administration. To facilitate large-scale production of CTB for vaccine development purposes, we have constructed recombinant overexpression systems for CTB proteins in which the CTB gene is under the control of strong foreign (non-cholera) promoters and in which it is also possible to fuse oligonucleotides to the CTB gene and thereby achieve overexpression of hybrid proteins (Sanchez and Holmgren, 1989; Sanchez et al., 1988). We here expand these findings by describing overexpression of CTB by a constitutive tacP promoter as well as by the T7 RNA-polymerase promoter, and also by describing gene fusions leading to overexpression of several hybrid proteins between heat-stable E. coli enterotoxin (STa)-related peptides to either the amino or carboxy ends of CTB. Each of the hybrid proteins, when tested as immunogens in rabbits, stimulated significant anti-STa as well as anti-CTB antibody formation, although the anti-STa antibody levels attained (c.a. 1-15 micrograms/ml specific anti-STa immunoglobulin) were too low to give more than partial neutralization of STa intestinal challenge in baby mice. The hybrid proteins also had a near-native conformation, as apparent from their oligomeric nature and their strong reactivity with both a neutralizing antibody against the B subunit and a neutralizing monoclonal antibody (mAb) against STa.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsJ Sanchez, S Johansson, B Löwenadler, A M Svennerholm, J Holmgren
JournalResearch in microbiology (Res Microbiol) 1990 Sep-Oct Vol. 141 Issue 7-8 Pg. 971-9 ISSN: 0923-2508 [Print] FRANCE
PMID2101488 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Bacterial
  • Cholera Vaccines
  • Recombinant Fusion Proteins
  • Vaccines, Synthetic
  • Cholera Toxin
Topics
  • Administration, Oral
  • Amino Acid Sequence
  • Animals
  • Antibodies, Bacterial (biosynthesis)
  • Cholera Toxin (genetics, immunology)
  • Cholera Vaccines (administration & dosage, genetics, isolation & purification)
  • Molecular Sequence Data
  • Rabbits
  • Recombinant Fusion Proteins (genetics, immunology)
  • Vaccines, Synthetic (administration & dosage, genetics, isolation & purification)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: